However, in GBM, due to particular conditions and relative isolation of the CNS, perhaps the kinetics of PD-L1 is different, such that the immune system cells can only infiltrate the tumor in later phases when there is a rupture or facilitation of the blood–brain barrier. The gene discussed is CD274; the disease is glioblastoma.